SaraAntoinetteMonaghanMD
Pathology • Pittsburgh, PAHematopathology, Anatomic Pathology, Clinical Pathology
Associate Professor, Pathology, University of Texas Southwestern Medical Center, Southwestern Medical School
Dr. Monaghan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Lothrop Street
Pittsburgh, PA 15213Phone+1 412-647-0943Fax+1 412-647-4050
Education & Training
University of Texas Southwestern Medical CenterFellowship, Hematopathology, 2001 - 2003
McGaw Medical Center of Northwestern UniversityResidency, Pathology-Anatomic and Clinical, 1997 - 2001- McGaw Medical Center of Northwestern UniversityResidency, Emergency Medicine, 1995 - 1995
Mayo Clinic College of MedicineClass of 1995
Certifications & Licensure
PA State Medical License 2004 - 2024
IL State Medical License 1995 - 2020
TX State Medical License 2011 - 2017- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- 143 citationsZinc-induced copper deficiency: A report of three cases initially recognized on bone marrow examinationMonte S. Willis, Sara A. Monaghan, Michael L. Miller, Robert W. McKenna, Wiley D. Perkins
American Journal of Clinical Pathology. 2005-01-01 - 15 citationsImmunomodulatory drugs downregulate IKZF1 leading to expansion of hematopoietic progenitors with concomitant block of megakaryocytic maturationAiling Liu, Shirong Li, Vera S. Donnenberg, Jing Fu, Susanne M. Gollin
Haematologica. 2018-10-01 - 7 citationsMyeloid neoplasm with t(3;8)(q26;q24): Report of six cases and review of the literatureXiangdong Xu, Mu Su, Norman B. Levy, Arash Mohtashamian, Sara A. Monaghan
Leukemia & Lymphoma. 2014-01-08
Journal Articles
- Immunomodulatory Drugs Downregulate IKZF1 Leading to Expansion of Hematopoietic Progenitors with Concomitant Block of Megakaryocytic MaturationMarkus Y Mapara, Sara A Monaghan, Suzanne Lentzsch, Haematologica
Press Mentions
- Venetoclax in a Patient with a Blastic Plasmacytoid Dendritic-Cell NeoplasmOctober 11th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
